Today, the Cystic Fibrosis Foundation announced that it has awarded up to $400,000 to Life Edit Therapeutics Inc. to explore the application of their unique gene editing technology in CF.
Site Search
Showing 1 - 6 of 6 results
Press Release
|
|
3 min read
New funding will support clinical development of two novel therapies to address complications of cystic fibrosis
Press Release
|
|
3 min read
The studies aim to improve early detection of chronic lung allograft dysfunction (CLAD), the leading cause of lung transplant failures.
News
|
|
5 min read
News
|
|
3 min read
Foundation to fund up to $110 million for collaboration to accelerate the development of genetic therapies for CF
News
|
|
4 min read
The Foundation and Bakar Labs will support AVECRIS Pte Ltd and Nosis Biological Sciences as they pursue genetic therapies for cystic fibrosis with their novel technologies.
News
|
|
4 min read